The LES USA-Canada IUGI Sector is pleased to announce a combined webinar and sector-wide meeting at 2pm (ET), on Thursday, August 3. The webinar features a presentation by the NIH’s Peter Soukas, on technology transfer to developing countries, particularly “TT with the Human element: MenAfriVac.” The presentation of this interesting topic is especially notable as it features a previous IUGI Deal of Distinction winner.

MenAfriVac is a low-cost meningitis vaccine designed for use in sub-Saharan Africa. The pioneering vaccine, and the first one for developing countries that does not require constant refrigeration, is based upon a patent license from the NIH and FDA to PATH, and was subsequently sublicensed by PATH to SII under the Meningitis Vaccine Project, a partnership of PATH and the World Health Organization.